Composition
- Active ingredients
- PIPERAZINE CITRATE EQ 500MG BASE
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- PIPERAZINE CITRATE EQ 500MG BASE · TabletThis page
- PIPERAZINE CITRATE EQ 500MG BASE/5ML · SyrupNDA009102-001 · Discontinued
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA009102.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Antepar
- Active substance
- piperazine citrate
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Glaxosmithkline
- Status
- Discontinued
- FDA approval
- 25 Jan 1957
- Application
- NDA009102-003